It is tempting to speculate that certain autoimmune myositis disorders such as polymyositis or dermatomyositis, or other forms of musculoskeletal painful diseases could one day be mitigated or treated via an approach that upregulates FoxA2 activity in the muscles. The gene discussed is FOXA2; the disease is polymyositis.